Cesar Gonzalez-Alvarez

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.

Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 29, 2023

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD.

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD.

Journal: Journal of neuroinflammation

Published: April 08, 2022

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients.

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients.

Journal: Therapeutic advances in neurological disorders

Published: July 22, 2021

Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells.

Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: April 22, 2021

Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.

Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.

Journal: Multiple sclerosis and related disorders

Published: June 02, 2018

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: January 17, 2018

Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.

Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.

Journal: JAMA neurology

Published: June 13, 2017

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis.

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis.

Journal: Annals of clinical and translational neurology

Published: February 01, 2017

MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.

MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.

Journal: Scientific reports

Published: August 20, 2015

A matter of identity - Phenotype and differentiation potential of human somatic stem cells.

A matter of identity - Phenotype and differentiation potential of human somatic stem cells.

Journal: Stem cell research

Published: December 08, 2014

Cord blood Lin(-)CD45(-) embryonic-like stem cells are a heterogeneous population that lack self-renewal capacity.

Cord blood Lin(-)CD45(-) embryonic-like stem cells are a heterogeneous population that lack self-renewal capacity.

Journal: PloS one

Published: April 07, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026